Guillain-Barré Syndrome Treatment in Mumbai

Our Approach in Managing Guillain-Barré Syndrome

GBS management has two simultaneous priorities from the moment of diagnosis: stopping the immune attack and preventing the complications of paralysis.

Our GBS specialist neurologist team in Mumbai, India, runs both tracks in parallel: immunotherapy alongside respiratory monitoring and physiotherapy planning alongside nutritional support. This is not a condition where watchful waiting is acceptable.​

1. Emergency Assessment & Diagnosis

GBS must be recognised quickly. The clinical pattern is recognisable  the danger is in missing it.

• Progressive, symmetrical ascending weakness starting from the legs  within days to four weeks of onset
• Areflexia loss of deep tendon reflexes is an early and consistent sign
• Sensory symptoms  tingling, pain  often precede or accompany the weakness
• Antecedent illness history  60–70% of GBS cases are triggered by a preceding respiratory or gastrointestinal infection (Campylobacter, CMV, EBV, COVID-19)
• Autonomic dysfunction  heart rate variability, blood pressure fluctuation, bladder dysfunction

2. Confirmatory Investigations

• Nerve conduction study  differentiates AIDP (demyelinating), AMAN, and AMSAN subtypes; guides prognosis
• CSF analysis  classic albuminocytologic dissociation (elevated protein without elevated cells) in 80% of cases
• Anti-ganglioside antibody panel — anti-GM1, anti-GD1b, anti-GQ1b (positive in Miller Fisher variant with ophthalmoplegia and ataxia)
• Respiratory function — FVC and NIF monitoring every 4–6 hours in acute phase to detect impending respiratory failure

3. Immunotherapy - Stopping the Immune Attack

Two treatments have equivalent evidence in GBS. Both are superior to supportive care alone.

• IVIG therapy for GBS — intravenous immunoglobulin 0.4g/kg/day for 5 days; most commonly used first-line
• Plasma exchange (PLEX)  4–6 sessions over 8–10 days; equally effective, used where IVIG is contraindicated or unavailable
• Combination of both is not superior to either alone , an important point that prevents treatment escalation errors
• Treatment is most effective when initiated within 2 weeks of symptom onset

4. Respiratory Monitoring & ICU Care

Up to 30% of GBS patients require mechanical ventilation. This is the most life-threatening aspect of the condition.

• Criteria for ICU transfer: FVC < 20 ml/kg, inability to count to 20 in a single breath, rapid progression
• Elective intubation is safer than emergency intubation  our team makes this decision proactively
• Autonomic monitoring — continuous cardiac rhythm monitoring for bradycardia, tachycardia, and BP instability
• Nasogastric feeding where swallowing is compromised

5. Complication Prevention During Paralysis

Immobility in GBS creates its own risks that must be actively managed.

• DVT prophylaxis — LMWH and compression stockings from admission
• Pressure ulcer prevention — regular repositioning, appropriate mattress
• Pain management — neuropathic pain is significant in GBS; Gabapentin and opioids may both be needed
• Bladder care — urinary retention and catheterisation management
• Psychological support — being conscious and paralysed is profoundly distressing; mental health support is not optional

6. Rehabilitation & Nerve Recovery

Nerve recovery after GBS is the phase that determines long-term outcome. It starts while the patient is still in hospital.

• Early physiotherapy — passive range of motion to prevent contractures while paralysed
• Progressive active rehabilitation as motor function returns  graded strengthening and gait retraining
• Occupational therapy for fine motor and upper limb recovery
• Speech and swallowing therapy where bulbar involvement occurred
• Fatigue management — post-GBS fatigue can persist for months and requires structured intervention